134 related articles for article (PubMed ID: 27167504)
1. An improved method for introducing site-directed point mutation into the Toxoplasma gondii genome using CRISPR/Cas9.
Sugi T; Kato K; Weiss LM
Parasitol Int; 2016 Oct; 65(5 Pt B):558-562. PubMed ID: 27167504
[TBL] [Abstract][Full Text] [Related]
2. Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9.
Shen B; Brown KM; Lee TD; Sibley LD
mBio; 2014 May; 5(3):e01114-14. PubMed ID: 24825012
[TBL] [Abstract][Full Text] [Related]
3. Knockout of leucine aminopeptidase in Toxoplasma gondii using CRISPR/Cas9.
Zheng J; Jia H; Zheng Y
Int J Parasitol; 2015 Feb; 45(2-3):141-8. PubMed ID: 25444863
[TBL] [Abstract][Full Text] [Related]
4. A streamlined CRISPR/Cas9 approach for fast genome editing in
Winiger RR; Hehl AB
J Biol Methods; 2020; 7(4):e140. PubMed ID: 33564692
[No Abstract] [Full Text] [Related]
5. CRISPR/Cas9-Mediated Generation of Tetracycline Repressor-Based Inducible Knockdown in Toxoplasma gondii.
Jacot D; Soldati-Favre D
Methods Mol Biol; 2020; 2071():125-141. PubMed ID: 31758450
[TBL] [Abstract][Full Text] [Related]
6. Single- and duplex TaqMan-quantitative PCR for determining the copy numbers of integrated selection markers during site-specific mutagenesis in Toxoplasma gondii by CRISPR-Cas9.
Hänggeli KPA; Hemphill A; Müller N; Schimanski B; Olias P; Müller J; Boubaker G
PLoS One; 2022; 17(9):e0271011. PubMed ID: 36112587
[TBL] [Abstract][Full Text] [Related]
7. New and emerging uses of CRISPR/Cas9 to genetically manipulate apicomplexan parasites.
Di Cristina M; Carruthers VB
Parasitology; 2018 Aug; 145(9):1119-1126. PubMed ID: 29463318
[TBL] [Abstract][Full Text] [Related]
8. The Past, Present, and Future of Genetic Manipulation in Toxoplasma gondii.
Wang JL; Huang SY; Behnke MS; Chen K; Shen B; Zhu XQ
Trends Parasitol; 2016 Jul; 32(7):542-553. PubMed ID: 27184069
[TBL] [Abstract][Full Text] [Related]
9. A Guide to Computational Tools and Design Strategies for Genome Editing Experiments in Zebrafish Using CRISPR/Cas9.
Prykhozhij SV; Rajan V; Berman JN
Zebrafish; 2016 Feb; 13(1):70-3. PubMed ID: 26683213
[TBL] [Abstract][Full Text] [Related]
10. Optimized CRISPR-Cas9 Genome Editing for
Zhang WW; Lypaczewski P; Matlashewski G
mSphere; 2017; 2(1):. PubMed ID: 28124028
[TBL] [Abstract][Full Text] [Related]
11. Toxoplasma gondii: the model apicomplexan.
Kim K; Weiss LM
Int J Parasitol; 2004 Mar; 34(3):423-32. PubMed ID: 15003501
[TBL] [Abstract][Full Text] [Related]
12. Investigative study on the role of the Toxo 5699 gene in the Toxoplasma gondii lytic cycle using the CRISPR/Cas9 system.
De Silva JR; Ching XT; Lau YL
Trop Biomed; 2020 Jun; 37(2):324-332. PubMed ID: 33612802
[TBL] [Abstract][Full Text] [Related]
13. Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs.
Xu P; Tong Y; Liu XZ; Wang TT; Cheng L; Wang BY; Lv X; Huang Y; Liu DP
Sci Rep; 2015 Jul; 5():12065. PubMed ID: 26156589
[TBL] [Abstract][Full Text] [Related]
14. PCR Screening of Toxoplasma gondii Single Clones Directly from 96-Well Plates Without DNA Purification.
Piro F; Carruthers VB; Di Cristina M
Methods Mol Biol; 2020; 2071():117-123. PubMed ID: 31758449
[TBL] [Abstract][Full Text] [Related]
15. Application of the CRISPR/Cas9 gene editing technique to research on functional genomes of parasites.
Cui Y; Yu L
Parasitol Int; 2016 Dec; 65(6 Pt A):641-644. PubMed ID: 27586395
[TBL] [Abstract][Full Text] [Related]
16. One-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces.
Huang H; Zheng G; Jiang W; Hu H; Lu Y
Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):231-43. PubMed ID: 25739462
[TBL] [Abstract][Full Text] [Related]
17. The CRISPR/Cas9 system produces specific and homozygous targeted gene editing in rice in one generation.
Zhang H; Zhang J; Wei P; Zhang B; Gou F; Feng Z; Mao Y; Yang L; Zhang H; Xu N; Zhu JK
Plant Biotechnol J; 2014 Aug; 12(6):797-807. PubMed ID: 24854982
[TBL] [Abstract][Full Text] [Related]
18. Role of mouse and human autophagy proteins in IFN-γ-induced cell-autonomous responses against Toxoplasma gondii.
Ohshima J; Lee Y; Sasai M; Saitoh T; Su Ma J; Kamiyama N; Matsuura Y; Pann-Ghill S; Hayashi M; Ebisu S; Takeda K; Akira S; Yamamoto M
J Immunol; 2014 Apr; 192(7):3328-35. PubMed ID: 24563254
[TBL] [Abstract][Full Text] [Related]
19. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.
Schumann K; Lin S; Boyer E; Simeonov DR; Subramaniam M; Gate RE; Haliburton GE; Ye CJ; Bluestone JA; Doudna JA; Marson A
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10437-42. PubMed ID: 26216948
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-Mediated Genome Editing in Soybean Hairy Roots.
Cai Y; Chen L; Liu X; Sun S; Wu C; Jiang B; Han T; Hou W
PLoS One; 2015; 10(8):e0136064. PubMed ID: 26284791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
